Skip to content Skip to navigation

MCAO (Experimental Middle Cerebral Artery Ischemia and Functional Recovery)

Middle Cerebral Artery Occlusion (MCAO) involves temporarily or permanently restricting middle cerebral arterty blood flow to the cortex and striatum by inserting intraluminal suture in the internal carotid via an incision in the external carotid.

The suture lodges in the junction between the anterior and middle cerebral arteries and remains in place either for a predetermined amount of time or permanently. Depending on the duration of the occlusion, damage occurs in the frontal, parietal, temporal, and occipital cortex as well as several subcortical structures including the thalamus, striatum, and hypothalamus.

MCAO

Carbenoxolone (CBX), a gap junction blocker and modulator of 11-ß-hydroxysteroid dehydrogenases, shows neuroprotective activity with reduced infarction when administered up to six hours post-MCAo in rats.

 
MCAO2

There is a 32 percent reduction in blood flow measures from baseline, after MCAO.

 

MCAO3